Immunocore Holdings (IMCR) Gross Margin (2023 - 2026)

Immunocore Holdings has disclosed Gross Margin across 4 years of filings, most recently posting 99.59% for Q1 2026.

• Gross Margin for Q1 2026 came in at 99.59%, up 48.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 98.86% (down 14.0% YoY), and the FY2025 annual result was 98.73%, down 39.0% from the prior year.
• Gross Margin came in at 99.59% for Q1 2026 at Immunocore Holdings, up from 97.41% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 99.71% in Q4 2023 to a low of 97.41% in Q4 2025.
• The 4-year median for Gross Margin is 99.51% (2025), against an average of 99.18%.
• Peak annual rise in Gross Margin reached 120 bps in 2025, while the deepest fall reached 219 bps in 2025.
• Immunocore Holdings' Gross Margin stood at 99.71% in 2023, then declined by 0 bps to 99.61% in 2024, then decreased by 2 bps to 97.41% in 2025, then increased by 2 bps to 99.59% in 2026.
• The last three Gross Margin figures came in at 99.59% (Q1 2026), 97.41% (Q4 2025), and 99.51% (Q3 2025), per Business Quant data.